Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven ...

In addition to an injector pen, this brand of tirzepatide is available in single-use vials ranging from 2.5 to 15 mg. Compounded semaglutide and tirzepatide: These are versions of the name-brand ...

Tirzepatide, the active ingredient in Eli Lilly ... cheaper version of Mounjaro and Zepbound (which comes in a vial instead of an injector pen), the price per month, which ranges from $400 ...

Both tirzepatide (Mounjaro for T2D; Zepbound for obesity) and semaglutide have periodically been in shortage due to the ever-escalating demand for the drugs for weight loss. When a drug is ...

The company also has worked on making tirzepatide less expensive to produce. Patients self-administer these drugs with an injection pen weekly, but Lilly recently launched single dose vials -- an ...